A detailed history of Northern Trust Corp transactions in Alpha Tau Medical Ltd. stock. As of the latest transaction made, Northern Trust Corp holds 22,896 shares of DRTS stock, worth $52,660. This represents 0.0% of its overall portfolio holdings.

Number of Shares
22,896
Previous 23,272 1.62%
Holding current value
$52,660
Previous $58,000 6.9%
% of portfolio
0.0%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$2.01 - $2.55 $755 - $958
-376 Reduced 1.62%
22,896 $54,000
Q2 2024

Aug 14, 2024

SELL
$2.05 - $2.9 $3,013 - $4,263
-1,470 Reduced 5.94%
23,272 $58,000
Q1 2024

May 14, 2024

SELL
$2.84 - $3.35 $9,065 - $10,693
-3,192 Reduced 11.43%
24,742 $72,000
Q4 2023

Feb 13, 2024

BUY
$2.75 - $3.89 $76,818 - $108,663
27,934 New
27,934 $84,000

Others Institutions Holding DRTS

About Alpha Tau Medical Ltd.


  • Ticker DRTS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 69,011,296
  • Market Cap $159M
  • Description
  • Alpha Tau Medical Ltd., a clinical-stage oncology therapeutics company, engages in research, development, and commercialization of diffusing alpha-emitters radiation therapy (Alpha DaRT) for the treatment of solid cancer In Israel and the United States. Its Alpha-DaRT technology used in clinical trials for skin, oral, pancreatic, and breast canc...
More about DRTS
Track This Portfolio

Track Northern Trust Corp Portfolio

Follow Northern Trust Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Northern Trust Corp, based on Form 13F filings with the SEC.

News

Stay updated on Northern Trust Corp with notifications on news.